Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Other financing activities (2024)

Historic Other financing activities for Kestra Medical Technologies (KMTS) over the last 1 years, with Q3 2024 value amounting to $3.2 million.

  • Kestra Medical Technologies' Other financing activities changed N/A to $3.2 million in Q3 2024 from the same period last year, while for Apr 2025 it was $3.2 million, marking a year-over-year change of. This contributed to the annual value of $3.2 million for FY2025, which is 3701.66% up from last year.
  • Per Kestra Medical Technologies' latest filing, its Other financing activities stood at $3.2 million for Q3 2024.
  • Over the past 5 years, Kestra Medical Technologies' Other financing activities peaked at $3.2 million during Q3 2024, and registered a low of $1000.0 during Q2 2024.